US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

IDEAYA Biosciences

37.59

+0.14000.37%

Post-market: 37.590.00000.00%19:30 EDT

Volume:429.25K

Turnover:16.16M

Market Cap:3.62B

PE:-19.22

High:38.27

Open:37.74

Low:37.24

Close:37.45

52wk High:42.68

52wk Low:24.24

Shares:96.27M

Float Shares:94.37M

Volume Ratio:0.75

T/O Rate:0.45%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.9561

EPS(LYR):-1.2849

ROE:-16.22%

ROA:-11.54%

PB:3.02

PE(LYR):-29.25

Loading ...

Overview Company News Filings

Ideaya Biosciences Stock Jumps 16% on Eye Cancer Therapy Trial Results

IDEAYA Eye Cancer Trial Data Beats Standard Therapy, Stock Soars

Benzinga_recent_news

Top Premarket Gainers

MT Newswires Live

Stock Track | IDEAYA Biosciences Soars 31.15% in Pre-market on Positive Phase 2/3 Trial Results for Eye Cancer Drug

Ideaya Biosciences Shares Jump on Trial Results

BUZZ-IDEAYA Biosciences surges after eye cancer drug combo improves survival in trial

Ideaya Biosciences, Servier announce topline results from OptimUM-02 trial

U.S. Stocks to Watch: Goldman Sachs, SanDisk, Exxon Mobil, Nvidia, Ideaya, and More

Tiger Newspress

Ideaya eye cancer drug meets main goal of mid-to-late-stage trial

IDEAYA says darovasertib-crizotinib trial cuts progression risk 58% in metastatic uveal melanoma

IDEAYA Biosciences Shares Gain 18% Premarket Ahead of Data Release for Its Experimental Cancer Drug

THOMSON REUTERS

IDEAYA Biosciences Inc - Trial Met Primary Endpoint Showing Statistically Significant Improvement in Median Pfs by Bicr

THOMSON REUTERS

IDEAYA Biosciences Inc - Nda Submission Planned for Second Half of 2026 to Support U.S. Accelerated Approval

THOMSON REUTERS

IDEAYA Biosciences and Servier Announce Positive Topline Results From Phase 2/3 Registrational Trial (Optimum-02) of Darovasertib in Combination With Crizotinib in First-Line Hla-a*02:01-Negative Metastatic Uveal Melanoma

THOMSON REUTERS

Why IDEAYA Biosciences Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket

Benzinga_recent_news

Analysts Offer Insights on Healthcare Companies: IDEAYA Biosciences (IDYA) and Certara (CERT)

Ideaya Biosciences Shares Gain Ahead of Trial Results

BRIEF-Ideaya Biosciences To Announce Topline Results From Phase 2/3 Optimum-02 Trial In Metastatic Uveal Melanoma On Monday, April 13, 2026

IDEAYA to report topline OptimUM-02 darovasertib-crizotinib trial results April 13

IDEAYA Biosciences to Announce Topline Results From Phase 2/3 Optimum-02 Trial in Metastatic Uveal Melanoma on Monday, April 13, 2026

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/IDYA/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IDYA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDYA\",,,,,undefined,":{"symbol":"IDYA","market":"US","secType":"STK","nameCN":"IDEAYA Biosciences","latestPrice":37.59,"timestamp":1789156800000,"preClose":37.45,"halted":0,"volume":429248,"hourTrading":{"tag":"盘后","latestPrice":37.59,"preClose":37.59,"latestTime":"19:30 EDT","volume":21201,"amount":796964.34,"timestamp":1789169405457,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.0037383177570093607,"floatShares":94374456,"shares":96274800,"eps":-1.956123,"marketStatus":"Market Closed","change":0.14,"latestTime":"09-11 16:00:00 EDT","open":37.74,"high":38.27,"low":37.24,"amount":16163067.306240002,"amplitude":0.027503,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.956123,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"listingDate":1558584000000,"exchange":"NASDAQ","adjPreClose":37.45,"preHourTrading":{"tag":"盘前","latestPrice":38.28,"preClose":37.45,"latestTime":"09:28 EDT","volume":312,"amount":11692.135104,"timestamp":1789133280075,"change":0.83,"changeRate":0.022163,"amplitude":0.093458},"postHourTrading":{"tag":"盘后","latestPrice":37.59,"preClose":37.59,"latestTime":"19:30 EDT","volume":21201,"amount":796964.34,"timestamp":1789169405457,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.7509056394765588,"impliedVol":0.6477,"impliedVolPercentile":0.3347},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDYA\",,,,,undefined,":{"symbol":"IDYA","floatShares":94374456,"roa":"-11.54%","roe":"-16.22%","lyrEps":-1.284937,"volumeRatio":0.7509056394765588,"shares":96274800,"dividePrice":0,"high":38.27,"amplitude":0.027503,"preClose":37.45,"low":37.24,"week52Low":24.238,"pbRate":"3.02","psRate":"15.46","week52High":42.68,"institutionHeld":0,"latestPrice":37.59,"eps":-1.956123,"divideRate":0,"volume":429248,"delay":0,"ttmEps":-1.956123,"open":37.74,"prevYearClose":34.57,"prevWeekClose":39.86,"prevMonthClose":40.1,"prevQuarterClose":37.27,"fiveDayClose":39.97,"twentyDayClose":36.68,"sixtyDayClose":30.57},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IDYA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-04","symbol":"IDYA","fiscalQuarterEnding":"2026/06","expectedEps":-1.18,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785816000000,"reportTimeType":"pre","actualEps":-1.22},{"market":"US","date":"2026-05-05","symbol":"IDYA","fiscalQuarterEnding":"2026/03","expectedEps":-1.07,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1777953600000,"reportTimeType":"pre","actualEps":-1.11},{"date":"2026-02-17","symbol":"IDYA","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771318800000,"name":null,"time":"Pre-MKt","dateTimestamp":1771304400000,"actualEps":null},{"market":"US","date":"2025-11-04","symbol":"IDYA","fiscalQuarterEnding":"2025/09","expectedEps":0,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762232400000,"reportTimeType":"pre","actualEps":1.33},{"market":"US","date":"2025-08-05","symbol":"IDYA","fiscalQuarterEnding":"2025/06","expectedEps":-0.85,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754366400000,"reportTimeType":"pre","actualEps":-0.88}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IDYA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IDYA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2667,"buy":0.6667,"hold":0.0667,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":15,"updateTime":1764043200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IDYA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IDYA","date":"2026-09-11","current":-19.216583,"percent":0.315147,"low":-34.624829,"twenty":-23.338475,"median":-17.608694,"eighty":-8.451147,"high":-4.624403,"avg":-16.843302,"sd":7.426972,"marketCap":3613531175},"quantilePoints":[{"date":"2021-09-17","current":-34.343535,"twenty":-18.002071,"median":-7.384758,"eighty":-3.550496,"marketCap":1031302001},{"date":"2021-09-24","current":-32.451188,"twenty":-18.564804,"median":-7.425593,"eighty":-3.554316,"marketCap":974476724},{"date":"2021-10-01","current":-32.655766,"twenty":-19.003246,"median":-7.482701,"eighty":-3.556676,"marketCap":980619997},{"date":"2021-10-08","current":-32.70691,"twenty":-19.603951,"median":-7.576366,"eighty":-3.556676,"marketCap":982155815},{"date":"2021-10-15","current":-29.57431,"twenty":-19.948284,"median":-7.607522,"eighty":-3.556676,"marketCap":888086943},{"date":"2021-10-22","current":-29.305801,"twenty":-20.299726,"median":-7.64547,"eighty":-3.561126,"marketCap":880023897},{"date":"2021-10-29","current":-27.413454,"twenty":-20.498333,"median":-7.666222,"eighty":-3.5648,"marketCap":823198619},{"date":"2021-11-05","current":-30.149685,"twenty":-20.989624,"median":-7.758551,"eighty":-3.569714,"marketCap":905364899},{"date":"2021-11-12","current":-29.446448,"twenty":-21.062795,"median":-7.793103,"eighty":-3.570043,"marketCap":884247397},{"date":"2021-11-19","current":-24.362497,"twenty":-21.240496,"median":-7.827655,"eighty":-3.571919,"marketCap":893738217},{"date":"2021-11-26","current":-24.981527,"twenty":-21.39159,"median":-7.890477,"eighty":-3.574612,"marketCap":916447328},{"date":"2021-12-03","current":-23.145422,"twenty":-21.857223,"median":-7.96045,"eighty":-3.584136,"marketCap":849089797},{"date":"2021-12-10","current":-22.914597,"twenty":-22.068374,"median":-8.022404,"eighty":-3.586999,"marketCap":840621993},{"date":"2021-12-17","current":-22.841153,"twenty":-22.307678,"median":-8.080851,"eighty":-3.590242,"marketCap":837927691},{"date":"2021-12-23","current":-24.519878,"twenty":-22.478131,"median":-8.112599,"eighty":-3.600896,"marketCap":899511720},{"date":"2021-12-31","current":-24.803163,"twenty":-22.661484,"median":-8.124771,"eighty":-3.607486,"marketCap":909904025},{"date":"2022-01-07","current":-18.854181,"twenty":-22.696715,"median":-8.133171,"eighty":-3.607884,"marketCap":691665623},{"date":"2022-01-14","current":-18.6968,"twenty":-22.661484,"median":-8.166895,"eighty":-3.6108,"marketCap":685892120},{"date":"2022-01-21","current":-16.01084,"twenty":-22.62885,"median":-8.217153,"eighty":-3.61443,"marketCap":587357674},{"date":"2022-01-28","current":-16.304617,"twenty":-22.589226,"median":-8.232117,"eighty":-3.61955,"marketCap":598134879},{"date":"2022-02-04","current":-16.336093,"twenty":-22.528306,"median":-8.279975,"eighty":-3.626979,"marketCap":599289580},{"date":"2022-02-11","current":-15.95838,"twenty":-22.480222,"median":-8.317669,"eighty":-3.641021,"marketCap":585433173},{"date":"2022-02-18","current":-14.290147,"twenty":-22.452959,"median":-8.349952,"eighty":-3.663377,"marketCap":524234045},{"date":"2022-02-25","current":-14.300639,"twenty":-22.416661,"median":-8.361644,"eighty":-3.680345,"marketCap":524618945},{"date":"2022-03-04","current":-12.663882,"twenty":-22.374982,"median":-8.467308,"eighty":-3.689682,"marketCap":464574517},{"date":"2022-03-11","current":-13.4298,"twenty":-22.27281,"median":-8.578381,"eighty":-3.700816,"marketCap":492672230},{"date":"2022-03-18","current":-9.803903,"twenty":-22.210534,"median":-8.63295,"eighty":-3.710538,"marketCap":487861813},{"date":"2022-03-25","current":-8.880178,"twenty":-22.137363,"median":-8.648165,"eighty":-3.728362,"marketCap":441895419},{"date":"2022-04-01","current":-8.849128,"twenty":-22.038758,"median":-8.676953,"eighty":-3.732947,"marketCap":440350330},{"date":"2022-04-08","current":-8.771505,"twenty":-22.005987,"median":-8.686118,"eighty":-3.735526,"marketCap":436487608},{"date":"2022-04-14","current":-8.39891,"twenty":-21.980806,"median":-8.678356,"eighty":-3.739591,"marketCap":417946542},{"date":"2022-04-22","current":-8.297999,"twenty":-21.967416,"median":-8.654251,"eighty":-3.742674,"marketCap":412925003},{"date":"2022-04-29","current":-7.445176,"twenty":-21.940847,"median":-8.644345,"eighty":-3.747479,"marketCap":370486844},{"date":"2022-05-06","current":-7.080292,"twenty":-21.836317,"median":-8.631683,"eighty":-3.752283,"marketCap":352329512},{"date":"2022-05-13","current":-7.388684,"twenty":-21.606351,"median":-8.578381,"eighty":-3.771501,"marketCap":404559983},{"date":"2022-05-20","current":-7.762705,"twenty":-21.554086,"median":-8.467308,"eighty":-3.779737,"marketCap":425039142},{"date":"2022-05-27","current":-7.621565,"twenty":-21.406546,"median":-8.392554,"eighty":-3.780239,"marketCap":417311157},{"date":"2022-06-03","current":-8.397835,"twenty":-21.39159,"median":-8.36786,"eighty":-3.788369,"marketCap":459815071},{"date":"2022-06-10","current":-8.037928,"twenty":-21.387041,"median":-8.380207,"eighty":-3.794466,"marketCap":440108711},{"date":"2022-06-17","current":-8.729514,"twenty":-21.336664,"median":-8.392554,"eighty":-3.799547,"marketCap":477975835},{"date":"2022-06-24","current":-9.795122,"twenty":-21.273946,"median":-8.39891,"eighty":-3.80666,"marketCap":536322117},{"date":"2022-07-01","current":-10.10563,"twenty":-21.225131,"median":-8.471248,"eighty":-3.810725,"marketCap":553323683},{"date":"2022-07-08","current":-10.888958,"twenty":-21.198073,"median":-8.557964,"eighty":-3.815416,"marketCap":596213996},{"date":"2022-07-15","current":-10.938357,"twenty":-21.154154,"median":-8.623821,"eighty":-3.823859,"marketCap":598918791},{"date":"2022-07-22","current":-10.50788,"twenty":-21.113328,"median":-8.640812,"eighty":-3.827243,"marketCap":575348438},{"date":"2022-07-29","current":-10.529051,"twenty":-21.08161,"median":-8.648165,"eighty":-3.852269,"marketCap":576507636},{"date":"2022-08-05","current":-11.107725,"twenty":-21.062795,"median":-8.674304,"eighty":-3.89073,"marketCap":608192372},{"date":"2022-08-12","current":-11.044212,"twenty":-21.057369,"median":-8.686118,"eighty":-3.902788,"marketCap":604714779},{"date":"2022-08-19","current":-6.087169,"twenty":-21.027635,"median":-8.674304,"eighty":-3.912344,"marketCap":400919180},{"date":"2022-08-26","current":-5.735068,"twenty":-20.992994,"median":-8.648165,"eighty":-3.917696,"marketCap":377728757},{"date":"2022-09-02","current":-5.597808,"twenty":-20.953825,"median":-8.640812,"eighty":-3.930533,"marketCap":368688422},{"date":"2022-09-09","current":-5.520226,"twenty":-20.872033,"median":-8.630797,"eighty":-3.94283,"marketCap":363578668},{"date":"2022-09-16","current":-7.849101,"twenty":-20.73156,"median":-8.578381,"eighty":-3.96417,"marketCap":516965327},{"date":"2022-09-23","current":-8.510226,"twenty":-20.611725,"median":-8.513329,"eighty":-3.972574,"marketCap":560509001},{"date":"2022-09-30","current":-10.493601,"twenty":-20.565232,"median":-8.578381,"eighty":-3.993719,"marketCap":691140025},{"date":"2022-10-07","current":-10.198204,"twenty":-20.477427,"median":-8.630797,"eighty":-4.008882,"marketCap":671684341},{"date":"2022-10-14","current":-10.950762,"twenty":-20.387531,"median":-8.642079,"eighty":-4.009677,"marketCap":721250013},{"date":"2022-10-21","current":-11.562654,"twenty":-20.357199,"median":-8.654251,"eighty":-4.014693,"marketCap":761551073},{"date":"2022-10-28","current":-11.956516,"twenty":-20.32892,"median":-8.675551,"eighty":-4.030286,"marketCap":787491986},{"date":"2022-11-04","current":-12.005748,"twenty":-20.283001,"median":-8.686118,"eighty":-4.065307,"marketCap":790734600},{"date":"2022-11-11","current":-15.768029,"twenty":-20.180562,"median":-8.713449,"eighty":-4.079563,"marketCap":830439027},{"date":"2022-11-18","current":-16.115182,"twenty":-20.035419,"median":-8.773737,"eighty":-4.104617,"marketCap":848722157},{"date":"2022-11-25","current":-16.060368,"twenty":-20.023491,"median":-8.779267,"eighty":-4.104763,"marketCap":845835347},{"date":"2022-12-02","current":-16.425792,"twenty":-19.948284,"median":-8.800314,"eighty":-4.104763,"marketCap":865080747},{"date":"2022-12-09","current":-15.384334,"twenty":-19.937676,"median":-8.842235,"eighty":-4.115583,"marketCap":810231356},{"date":"2022-12-16","current":-15.39347,"twenty":-19.766046,"median":-8.880178,"eighty":-4.122926,"marketCap":810712491},{"date":"2022-12-23","current":-15.548775,"twenty":-19.620281,"median":-8.920409,"eighty":-4.130826,"marketCap":818891787},{"date":"2022-12-30","current":-16.599368,"twenty":-19.607217,"median":-8.936255,"eighty":-4.130945,"marketCap":874222313},{"date":"2023-01-06","current":-15.777165,"twenty":-19.59823,"median":-8.94733,"eighty":-4.146129,"marketCap":830920162},{"date":"2023-01-13","current":-17.101825,"twenty":-19.554345,"median":-9.043188,"eighty":-4.162328,"marketCap":900684738},{"date":"2023-01-20","current":-16.106046,"twenty":-19.478065,"median":-9.066475,"eighty":-4.171098,"marketCap":848241022},{"date":"2023-01-27","current":-15.420877,"twenty":-19.243528,"median":-9.155743,"eighty":-4.18158,"marketCap":812155896},{"date":"2023-02-03","current":-16.042097,"twenty":-18.988351,"median":-9.163635,"eighty":-4.19168,"marketCap":844873077},{"date":"2023-02-10","current":-16.416656,"twenty":-18.921278,"median":-9.21308,"eighty":-4.201222,"marketCap":864599612},{"date":"2023-02-17","current":-16.16086,"twenty":-18.818457,"median":-9.237619,"eighty":-4.208561,"marketCap":851127832},{"date":"2023-02-24","current":-15.567046,"twenty":-18.755454,"median":-9.279961,"eighty":-4.218427,"marketCap":819854057},{"date":"2023-03-03","current":-15.7863,"twenty":-18.713587,"median":-9.288903,"eighty":-4.239786,"marketCap":831401297},{"date":"2023-03-10","current":-12.695923,"twenty":-18.685623,"median":-9.337354,"eighty":-4.268913,"marketCap":744679346},{"date":"2023-03-17","current":-12.365944,"twenty":-18.625694,"median":-9.47488,"eighty":-4.277714,"marketCap":725324457},{"date":"2023-03-24","current":-11.450254,"twenty":-18.520909,"median":-9.51831,"eighty":-4.30099,"marketCap":671614641},{"date":"2023-03-31","current":-11.326512,"twenty":-18.333889,"median":-9.637448,"eighty":-4.31253,"marketCap":664356558},{"date":"2023-04-06","current":-11.343011,"twenty":-18.288121,"median":-9.673933,"eighty":-4.318821,"marketCap":665324302},{"date":"2023-04-14","current":-11.433755,"twenty":-18.224659,"median":-9.699267,"eighty":-4.318821,"marketCap":670646896},{"date":"2023-04-21","current":-12.012005,"twenty":-18.140723,"median":-9.745723,"eighty":-4.318821,"marketCap":704564136},{"date":"2023-04-28","current":-17.665967,"twenty":-18.140723,"median":-9.757173,"eighty":-4.324014,"marketCap":1036197283},{"date":"2023-05-05","current":-18.5444,"twenty":-18.345331,"median":-9.795122,"eighty":-4.333623,"marketCap":1087721785},{"date":"2023-05-12","current":-17.975574,"twenty":-18.548481,"median":-9.809491,"eighty":-4.342105,"marketCap":1227408161},{"date":"2023-05-19","current":-17.7789,"twenty":-18.385145,"median":-9.923908,"eighty":-4.345574,"marketCap":1213978850},{"date":"2023-05-26","current":-18.14807,"twenty":-18.548481,"median":-10.050322,"eighty":-4.359142,"marketCap":1239186528},{"date":"2023-06-02","current":-20.069433,"twenty":-18.624,"median":-10.097881,"eighty":-4.366759,"marketCap":1370381033},{"date":"2023-06-09","current":-21.42026,"twenty":-18.679679,"median":-10.133562,"eighty":-4.369631,"marketCap":1462618218},{"date":"2023-06-16","current":-20.925237,"twenty":-18.866911,"median":-10.16981,"eighty":-4.375728,"marketCap":1428817014},{"date":"2023-06-23","current":-21.134993,"twenty":-18.937913,"median":-10.21543,"eighty":-4.380543,"marketCap":1443139558},{"date":"2023-06-30","current":-19.937075,"twenty":-19.13128,"median":-10.25893,"eighty":-4.382308,"marketCap":1361343322},{"date":"2023-07-07","current":-19.327719,"twenty":-19.403716,"median":-10.300042,"eighty":-4.384874,"marketCap":1319735326},{"date":"2023-07-14","current":-19.516534,"twenty":-19.527631,"median":-10.366739,"eighty":-4.396081,"marketCap":1332627944},{"date":"2023-07-21","current":-18.778441,"twenty":-19.516534,"median":-10.433806,"eighty":-4.40569,"marketCap":1282229526},{"date":"2023-07-28","current":-18.083261,"twenty":-19.456456,"median":-10.472595,"eighty":-4.425522,"marketCap":1234761248},{"date":"2023-08-04","current":-18.684034,"twenty":-19.430709,"median":-10.508916,"eighty":-4.445846,"marketCap":1275783217},{"date":"2023-08-11","current":-19.793943,"twenty":-19.456456,"median":-10.529051,"eighty":-4.466169,"marketCap":1467760467},{"date":"2023-08-18","current":-19.297154,"twenty":-19.516534,"median":-10.56417,"eighty":-4.47125,"marketCap":1430922557},{"date":"2023-08-25","current":-21.788862,"twenty":-19.594416,"median":-10.725698,"eighty":-4.489816,"marketCap":1615687698},{"date":"2023-09-01","current":-22.790203,"twenty":-19.620281,"median":-10.783103,"eighty":-4.508424,"marketCap":1689939110},{"date":"2023-09-08","current":-21.773337,"twenty":-19.662379,"median":-10.81952,"eighty":-4.516812,"marketCap":1614536513},{"date":"2023-09-15","current":-22.891113,"twenty":-19.937195,"median":-10.874844,"eighty":-4.541754,"marketCap":1697421810},{"date":"2023-09-22","current":-21.88201,"twenty":-20.044607,"median":-10.927771,"eighty":-4.55153,"marketCap":1622594806},{"date":"2023-09-29","current":-20.640037,"twenty":-20.232827,"median":-10.973642,"eighty":-4.576935,"marketCap":1530500032},{"date":"2023-10-06","current":-20.546889,"twenty":-20.307025,"median":-10.998264,"eighty":-4.587214,"marketCap":1523592923},{"date":"2023-10-13","current":-21.191163,"twenty":-20.399581,"median":-11.044212,"eighty":-4.596272,"marketCap":1571367088},{"date":"2023-10-20","current":-20.127723,"twenty":-20.430908,"median":-11.063294,"eighty":-4.598275,"marketCap":1492510937},{"date":"2023-10-27","current":-22.829497,"twenty":-20.455558,"median":-11.08551,"eighty":-4.599291,"marketCap":1692852872},{"date":"2023-11-03","current":-25.350703,"twenty":-20.512907,"median":-11.133626,"eighty":-4.606404,"marketCap":1879805335},{"date":"2023-11-10","current":-18.349717,"twenty":-20.534125,"median":-11.159417,"eighty":-4.623679,"marketCap":1893819287},{"date":"2023-11-17","current":-18.699474,"twenty":-20.512907,"median":-11.219301,"eighty":-4.647268,"marketCap":1929916591},{"date":"2023-11-24","current":-19.986078,"twenty":-20.508077,"median":-11.235768,"eighty":-4.660326,"marketCap":2062703104},{"date":"2023-12-01","current":-19.642567,"twenty":-20.498333,"median":-11.326512,"eighty":-4.691605,"marketCap":2027250394},{"date":"2023-12-08","current":-19.523899,"twenty":-20.469266,"median":-11.343011,"eighty":-4.703566,"marketCap":2015003094},{"date":"2023-12-15","current":-21.372612,"twenty":-20.485729,"median":-11.403123,"eighty":-4.710056,"marketCap":2205803131},{"date":"2023-12-22","current":-21.178997,"twenty":-20.539127,"median":-11.433755,"eighty":-4.725299,"marketCap":2185820695},{"date":"2023-12-29","current":-22.378161,"twenty":-20.560916,"median":-11.460738,"eighty":-4.752445,"marketCap":2309582881},{"date":"2024-01-05","current":-21.616192,"twenty":-20.635863,"median":-11.478255,"eighty":-4.774704,"marketCap":2230942325},{"date":"2024-01-12","current":-24.694637,"twenty":-20.763319,"median":-11.573996,"eighty":-4.807425,"marketCap":2548659433},{"date":"2024-01-19","current":-28.378521,"twenty":-20.874895,"median":-11.672989,"eighty":-4.871722,"marketCap":2928862002},{"date":"2024-01-26","current":-30.347082,"twenty":-20.925237,"median":-11.754932,"eighty":-4.928537,"marketCap":3132031295},{"date":"2024-02-02","current":-31.796601,"twenty":-20.995241,"median":-11.84903,"eighty":-5.022175,"marketCap":3281631848},{"date":"2024-02-09","current":-31.989395,"twenty":-21.094154,"median":-11.907283,"eighty":-5.032659,"marketCap":3301529459},{"date":"2024-02-16","current":-33.160435,"twenty":-21.134993,"median":-12.008876,"eighty":-5.086047,"marketCap":3422389019},{"date":"2024-02-23","current":-29.405371,"twenty":-21.18143,"median":-12.106086,"eighty":-5.094177,"marketCap":3321660162},{"date":"2024-03-01","current":-29.504379,"twenty":-21.252364,"median":-12.196466,"eighty":-5.100274,"marketCap":3332844203},{"date":"2024-03-08","current":-29.854208,"twenty":-21.362618,"median":-12.275201,"eighty":-5.134457,"marketCap":3372361147},{"date":"2024-03-15","current":-29.570385,"twenty":-21.39159,"median":-12.312278,"eighty":-5.167912,"marketCap":3340300230},{"date":"2024-03-22","current":-30.118229,"twenty":-21.456111,"median":-12.35282,"eighty":-5.193104,"marketCap":3402185256},{"date":"2024-03-28","current":-28.586905,"twenty":-21.586005,"median":-12.411316,"eighty":-5.211962,"marketCap":3229205423},{"date":"2024-04-05","current":-27.326204,"twenty":-21.698819,"median":-12.663882,"eighty":-5.224529,"marketCap":3086795302},{"date":"2024-04-12","current":-28.685913,"twenty":-21.801282,"median":-12.695915,"eighty":-5.23565,"marketCap":3240389464},{"date":"2024-04-19","current":-24.831203,"twenty":-21.90599,"median":-12.746573,"eighty":-5.260951,"marketCap":2804957470},{"date":"2024-04-26","current":-25.561122,"twenty":-21.970513,"median":-12.778856,"eighty":-5.33492,"marketCap":2887409933},{"date":"2024-05-03","current":-27.460667,"twenty":-22.002271,"median":-12.852662,"eighty":-5.443511,"marketCap":3101984415},{"date":"2024-05-10","current":-23.864016,"twenty":-22.106629,"median":-13.01501,"eighty":-5.504053,"marketCap":3075904561},{"date":"2024-05-17","current":-24.386628,"twenty":-22.316456,"median":-13.122963,"eighty":-5.514677,"marketCap":3143265660},{"date":"2024-05-24","current":-22.578036,"twenty":-22.408348,"median":-13.19089,"eighty":-5.517064,"marketCap":2910150846},{"date":"2024-05-31","current":-21.016071,"twenty":-22.408348,"median":-13.405255,"eighty":-5.517064,"marketCap":2708824416},{"date":"2024-06-07","current":-23.270938,"twenty":-22.480222,"median":-13.492753,"eighty":-5.517064,"marketCap":2999461067},{"date":"2024-06-14","current":-22.859895,"twenty":-22.573944,"median":-13.658594,"eighty":-5.526194,"marketCap":2946480428},{"date":"2024-06-21","current":-21.297929,"twenty":-22.578036,"median":-13.849482,"eighty":-5.550065,"marketCap":2745153997},{"date":"2024-06-28","current":-20.18224,"twenty":-22.604654,"median":-14.065248,"eighty":-5.737455,"marketCap":2601349404},{"date":"2024-07-05","current":-19.548058,"twenty":-22.604654,"median":-14.207014,"eighty":-5.875249,"marketCap":2519607846},{"date":"2024-07-12","current":-25.833502,"twenty":-22.663386,"median":-14.56294,"eighty":-6.158782,"marketCap":3329757590},{"date":"2024-07-15","current":-26.081274,"twenty":-22.683944,"median":-14.611833,"eighty":-6.204137,"marketCap":3361693680},{"date":"2024-08-02","current":-27.685273,"twenty":-22.729538,"median":-15.101131,"eighty":-7.080248,"marketCap":3568437841},{"date":"2024-08-09","current":-20.650678,"twenty":-22.791755,"median":-15.174216,"eighty":-7.173892,"marketCap":3174814544},{"date":"2024-08-16","current":-20.941919,"twenty":-22.791755,"median":-15.356928,"eighty":-7.243187,"marketCap":3219589736},{"date":"2024-08-23","current":-21.062812,"twenty":-22.791755,"median":-15.420877,"eighty":-7.280035,"marketCap":3238175665},{"date":"2024-08-30","current":-21.524403,"twenty":-22.791755,"median":-15.493961,"eighty":-7.318659,"marketCap":3309140119},{"date":"2024-09-06","current":-20.53528,"twenty":-22.791755,"median":-15.548775,"eighty":-7.330832,"marketCap":3157073430},{"date":"2024-09-13","current":-19.842894,"twenty":-22.791755,"median":-15.658402,"eighty":-7.386643,"marketCap":3050626748},{"date":"2024-09-20","current":-19.386799,"twenty":-22.791755,"median":-15.731487,"eighty":-7.41883,"marketCap":2980507108},{"date":"2024-09-27","current":-16.76013,"twenty":-22.791755,"median":-15.7863,"eighty":-7.470507,"marketCap":2576685567},{"date":"2024-10-04","current":-16.073239,"twenty":-22.791755,"median":-15.877656,"eighty":-7.496684,"marketCap":2471083699},{"date":"2024-10-11","current":-16.595276,"twenty":-22.791755,"median":-15.923334,"eighty":-7.600254,"marketCap":2551341118},{"date":"2024-10-18","current":-16.864537,"twenty":-22.791755,"median":-15.959877,"eighty":-7.641123,"marketCap":2592737050},{"date":"2024-10-25","current":-16.045763,"twenty":-22.791755,"median":-16.042097,"eighty":-7.711567,"marketCap":2466859624},{"date":"2024-10-31","current":-16.188637,"twenty":-22.791755,"median":-16.087775,"eighty":-7.784511,"marketCap":2488824813},{"date":"2024-11-08","current":-14.552491,"twenty":-22.793308,"median":-16.087775,"eighty":-7.860776,"marketCap":2592089652},{"date":"2024-11-15","current":-14.300163,"twenty":-22.793308,"median":-16.087775,"eighty":-7.961667,"marketCap":2547145116},{"date":"2024-11-22","current":-12.907511,"twenty":-22.793308,"median":-16.087775,"eighty":-8.046396,"marketCap":2299085853},{"date":"2024-11-29","current":-13.276297,"twenty":-22.793308,"median":-16.087775,"eighty":-8.103024,"marketCap":2364774020},{"date":"2024-12-06","current":-12.795905,"twenty":-22.793308,"median":-16.087775,"eighty":-8.12743,"marketCap":2279206539},{"date":"2024-12-13","current":-12.50961,"twenty":-22.793308,"median":-16.087775,"eighty":-8.178203,"marketCap":2228211778},{"date":"2024-12-20","current":-12.029218,"twenty":-22.793308,"median":-16.087775,"eighty":-8.232893,"marketCap":2142644297},{"date":"2024-12-27","current":-12.54843,"twenty":-22.793308,"median":-16.087775,"eighty":-8.272654,"marketCap":2235126322},{"date":"2025-01-03","current":-12.208758,"twenty":-22.793308,"median":-16.087775,"eighty":-8.306032,"marketCap":2174624062},{"date":"2025-01-10","current":-12.058333,"twenty":-22.79486,"median":-16.087775,"eighty":-8.349042,"marketCap":2147830205},{"date":"2025-01-17","current":-11.024761,"twenty":-22.79486,"median":-16.087775,"eighty":-8.387198,"marketCap":1963730473},{"date":"2025-01-24","current":-11.301351,"twenty":-22.79486,"median":-16.087775,"eighty":-8.421336,"marketCap":2012996598},{"date":"2025-01-31","current":-11.587645,"twenty":-22.79486,"median":-16.087775,"eighty":-8.512709,"marketCap":2063991360},{"date":"2025-02-07","current":-11.626465,"twenty":-22.79486,"median":-16.087775,"eighty":-8.629402,"marketCap":2070905904},{"date":"2025-02-14","current":-6.537248,"twenty":-22.79486,"median":-16.087775,"eighty":-8.645873,"marketCap":1794324147},{"date":"2025-02-21","current":-6.930226,"twenty":-22.79486,"median":-16.087775,"eighty":-8.645873,"marketCap":1902187506},{"date":"2025-02-28","current":-6.455028,"twenty":-22.79486,"median":-16.087775,"eighty":-8.645873,"marketCap":1771756793},{"date":"2025-03-07","current":-6.081887,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1669338046},{"date":"2025-03-14","current":-6.046805,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1659708933},{"date":"2025-03-21","current":-5.880964,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1614189490},{"date":"2025-03-28","current":-5.558851,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1525776725},{"date":"2025-04-04","current":-4.965652,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1362957177},{"date":"2025-04-11","current":-5.029437,"twenty":-22.79486,"median":-16.087775,"eighty":-8.645873,"marketCap":1380464656},{"date":"2025-04-17","current":-5.160196,"twenty":-22.79486,"median":-16.087775,"eighty":-8.645873,"marketCap":1416354986},{"date":"2025-04-25","current":-6.081887,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1669338046},{"date":"2025-05-02","current":-6.528381,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1791890393},{"date":"2025-05-09","current":-5.185048,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1592240087},{"date":"2025-05-16","current":-4.936919,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1516043779},{"date":"2025-05-23","current":-5.327651,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1636031068},{"date":"2025-05-30","current":-5.718383,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1756018358},{"date":"2025-06-06","current":-6.01785,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1847979419},{"date":"2025-06-13","current":-6.354393,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1951326135},{"date":"2025-06-20","current":-6.234607,"twenty":-22.797965,"median":-16.087775,"eighty":-8.644345,"marketCap":1914541711},{"date":"2025-06-27","current":-6.357245,"twenty":-22.797965,"median":-16.087775,"eighty":-8.623821,"marketCap":1952201955},{"date":"2025-07-03","current":-6.303056,"twenty":-22.797965,"median":-16.087775,"eighty":-8.578381,"marketCap":1935561382},{"date":"2025-07-11","current":-6.5027,"twenty":-22.797965,"median":-16.087775,"eighty":-8.537547,"marketCap":1996868756},{"date":"2025-07-18","current":-6.300204,"twenty":-22.797965,"median":-16.087775,"eighty":-8.47506,"marketCap":1934685562},{"date":"2025-07-25","current":-7.081669,"twenty":-22.797965,"median":-16.087775,"eighty":-8.47506,"marketCap":2174660141},{"date":"2025-08-01","current":-6.94477,"twenty":-22.797965,"median":-16.087775,"eighty":-8.47506,"marketCap":2132620799},{"date":"2025-08-08","current":-5.919479,"twenty":-22.797965,"median":-16.087775,"eighty":-8.47506,"marketCap":1964095003},{"date":"2025-08-15","current":-6.437202,"twenty":-22.797965,"median":-16.087775,"eighty":-8.47506,"marketCap":2135876627},{"date":"2025-08-22","current":-6.50588,"twenty":-22.797965,"median":-16.087775,"eighty":-8.47506,"marketCap":2158663986},{"date":"2025-08-29","current":-6.585123,"twenty":-22.797965,"median":-16.087775,"eighty":-8.47506,"marketCap":2184957091},{"date":"2025-09-05","current":-6.822853,"twenty":-22.800061,"median":-16.094245,"eighty":-8.503193,"marketCap":2263836409},{"date":"2025-09-12","current":-6.585123,"twenty":-22.797965,"median":-16.087775,"eighty":-8.47506,"marketCap":2184957091},{"date":"2025-09-19","current":-6.92587,"twenty":-22.797965,"median":-16.087775,"eighty":-8.47506,"marketCap":2298017446},{"date":"2025-09-26","current":-6.785873,"twenty":-22.797965,"median":-16.087775,"eighty":-8.47506,"marketCap":2251566293},{"date":"2025-10-03","current":-7.184731,"twenty":-22.797965,"median":-16.087775,"eighty":-8.47506,"marketCap":2383908259},{"date":"2025-10-10","current":-7.076432,"twenty":-22.797965,"median":-16.087775,"eighty":-8.426063,"marketCap":2347974347},{"date":"2025-10-17","current":-7.314162,"twenty":-22.797965,"median":-16.087775,"eighty":-8.383627,"marketCap":2426853665},{"date":"2025-10-24","current":-7.506988,"twenty":-22.797965,"median":-16.087775,"eighty":-8.36786,"marketCap":2490833556},{"date":"2025-10-31","current":-8.346967,"twenty":-22.797965,"median":-16.087775,"eighty":-8.39891,"marketCap":2769540477},{"date":"2025-11-07","current":-16.280273,"twenty":-22.797965,"median":-16.115182,"eighty":-8.446927,"marketCap":2616842278},{"date":"2025-11-14","current":-17.354717,"twenty":-22.797965,"median":-16.176647,"eighty":-8.45396,"marketCap":2789545102},{"date":"2025-11-21","current":-18.085556,"twenty":-22.797965,"median":-16.210617,"eighty":-8.45396,"marketCap":2907018089},{"date":"2025-11-28","current":-19.427247,"twenty":-22.797965,"median":-16.280273,"eighty":-8.45396,"marketCap":3122677452},{"date":"2025-12-05","current":-19.639954,"twenty":-22.797965,"median":-16.315109,"eighty":-8.45396,"marketCap":3156867352},{"date":"2025-12-12","current":-18.303718,"twenty":-22.797965,"median":-16.365703,"eighty":-8.45396,"marketCap":2942084652},{"date":"2025-12-19","current":-18.140097,"twenty":-22.797965,"median":-16.416656,"eighty":-8.45396,"marketCap":2915784730},{"date":"2025-12-26","current":-19.459971,"twenty":-22.797965,"median":-16.47147,"eighty":-8.45396,"marketCap":3127937437},{"date":"2026-01-02","current":-18.854574,"twenty":-22.797965,"median":-16.52495,"eighty":-8.45396,"marketCap":3030627724},{"date":"2026-01-09","current":-19.869024,"twenty":-22.797965,"median":-16.599368,"eighty":-8.45396,"marketCap":3193687243},{"date":"2026-01-16","current":-19.667225,"twenty":-22.797965,"median":-16.654182,"eighty":-8.45396,"marketCap":3161250672},{"date":"2026-01-23","current":-19.743581,"twenty":-22.797965,"median":-16.776759,"eighty":-8.45396,"marketCap":3173523969},{"date":"2026-01-30","current":-17.992838,"twenty":-22.797965,"median":-16.864537,"eighty":-8.45396,"marketCap":2892114799},{"date":"2026-02-06","current":-17.327447,"twenty":-22.797965,"median":-16.944631,"eighty":-8.45396,"marketCap":2785161782},{"date":"2026-02-13","current":-17.191096,"twenty":-22.797965,"median":-16.997091,"eighty":-8.45396,"marketCap":2763245180},{"date":"2026-02-20","current":-25.410135,"twenty":-22.829497,"median":-17.067857,"eighty":-8.45396,"marketCap":2889081488},{"date":"2026-02-27","current":-24.63779,"twenty":-22.859895,"median":-17.238205,"eighty":-8.45396,"marketCap":2801267461},{"date":"2026-03-06","current":-25.510539,"twenty":-22.975694,"median":-17.398349,"eighty":-8.45396,"marketCap":2900497311},{"date":"2026-03-13","current":-25.356071,"twenty":-23.059318,"median":-17.427264,"eighty":-8.45396,"marketCap":2882934506},{"date":"2026-03-20","current":-25.178431,"twenty":-23.145422,"median":-17.532711,"eighty":-8.45396,"marketCap":2862737280},{"date":"2026-03-27","current":-24.784536,"twenty":-23.270938,"median":-17.545608,"eighty":-8.45396,"marketCap":2817952126},{"date":"2026-04-02","current":-25.08575,"twenty":-23.407723,"median":-17.545608,"eighty":-8.45396,"marketCap":2852199596},{"date":"2026-04-10","current":-23.94268,"twenty":-23.579678,"median":-17.545608,"eighty":-8.45396,"marketCap":2722234837},{"date":"2026-04-17","current":-25.10892,"twenty":-23.717857,"median":-17.696952,"eighty":-8.45396,"marketCap":2854834017},{"date":"2026-04-24","current":-23.710977,"twenty":-23.781807,"median":-17.753729,"eighty":-8.45396,"marketCap":2695890628},{"date":"2026-05-01","current":-22.475225,"twenty":-23.781807,"median":-17.753729,"eighty":-8.45396,"marketCap":2555388185},{"date":"2026-05-08","current":-17.715337,"twenty":-23.781807,"median":-17.742113,"eighty":-8.45396,"marketCap":2481192380},{"date":"2026-05-15","current":-18.091725,"twenty":-23.781807,"median":-17.665967,"eighty":-8.45396,"marketCap":2533908932},{"date":"2026-05-22","current":-18.530845,"twenty":-23.781807,"median":-17.665967,"eighty":-8.45396,"marketCap":2595411576},{"date":"2026-05-29","current":-18.405382,"twenty":-23.784228,"median":-17.665782,"eighty":-8.452553,"marketCap":2577839392},{"date":"2026-06-05","current":-18.330104,"twenty":-23.781807,"median":-17.665596,"eighty":-8.45396,"marketCap":2567296082},{"date":"2026-06-12","current":-18.091725,"twenty":-23.781807,"median":-17.640059,"eighty":-8.45396,"marketCap":2533908932},{"date":"2026-06-18","current":-19.609824,"twenty":-23.781807,"median":-17.640059,"eighty":-8.45396,"marketCap":2746532359},{"date":"2026-06-26","current":-22.765212,"twenty":-23.784228,"median":-17.624377,"eighty":-8.452553,"marketCap":3188472786},{"date":"2026-07-02","current":-24.555061,"twenty":-23.887071,"median":-17.624377,"eighty":-8.452553,"marketCap":3439157354},{"date":"2026-07-10","current":-25.308617,"twenty":-24.08363,"median":-17.624377,"eighty":-8.452553,"marketCap":3544699645},{"date":"2026-07-17","current":-24.39213,"twenty":-24.253162,"median":-17.624377,"eighty":-8.452553,"marketCap":3416337399},{"date":"2026-07-24","current":-24.595794,"twenty":-24.196085,"median":-17.624377,"eighty":-8.452553,"marketCap":3444862343},{"date":"2026-07-31","current":-24.711204,"twenty":-24.166881,"median":-17.608694,"eighty":-8.451147,"marketCap":3461026478},{"date":"2026-08-07","current":-19.97931,"twenty":-24.08533,"median":-17.608694,"eighty":-8.451147,"marketCap":3496778900},{"date":"2026-08-14","current":-20.221885,"twenty":-23.924144,"median":-17.608694,"eighty":-8.451147,"marketCap":3539234273},{"date":"2026-08-21","current":-21.561557,"twenty":-23.777689,"median":-17.608694,"eighty":-8.451147,"marketCap":3773703719},{"date":"2026-08-28","current":-23.02803,"twenty":-23.690057,"median":-17.608694,"eighty":-8.451147,"marketCap":4030365746},{"date":"2026-09-04","current":-22.03568,"twenty":-23.537972,"median":-17.608694,"eighty":-8.451147,"marketCap":3856684675},{"date":"2026-09-11","current":-20.64639,"twenty":-23.338475,"median":-17.608694,"eighty":-8.451147,"marketCap":3613531175}],"updateTime":1789258796874},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IDYA\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2627764458","title":"Ideaya Biosciences Stock Jumps 16% on Eye Cancer Therapy Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2627764458","media":"Dow Jones","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627764458?lang=en_us&edition=fundamental","pubTime":"2026-04-13 20:46","pubTimestamp":1776084363,"startTime":"0","endTime":"0","summary":"Shares of $Ideaya Biosciences(IDYA)$ spiked in premarket trading Monday after the San Francisco-based biotech reported positive results from a trial evaluating its combination therapy for a rare eye...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Ideaya Biosciences Stock Jumps 16% on Eye Cancer Therapy Trial Results","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627430977","title":"IDEAYA Eye Cancer Trial Data Beats Standard Therapy, Stock Soars","url":"https://stock-news.laohu8.com/highlight/detail?id=2627430977","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627430977?lang=en_us&edition=fundamental","pubTime":"2026-04-13 19:48","pubTimestamp":1776080880,"startTime":"0","endTime":"0","summary":"IDEAYA shares rise after darovasertib trial shows progression-free survival benefit in uveal melanoma; NDA filing planned for 2026.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/04/13/Eye-In-Close-Up-With-Light-Blue-Iris-Det.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/04/13/Eye-In-Close-Up-With-Light-Blue-Iris-Det.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/26/04/51775855/ideaya-eye-cancer-trial-data-beats-standard-therapy-stock-soars","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/26/04/51775855/ideaya-eye-cancer-trial-data-beats-standard-therapy-stock-soars","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4217","RSI","SMA","BK4124","BK4211","SMP","BK4195","ORR","PFS","BK4139","IDYA","BK4150"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627437270","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2627437270","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627437270?lang=en_us&edition=fundamental","pubTime":"2026-04-13 19:36","pubTimestamp":1776080176,"startTime":"0","endTime":"0","summary":"Sky Quarry  shares were up 48% in Monday premarket activity, continuing Friday's surge.Battalion Oil  stock was 32% higher, erasing the previous session's loss.Ideaya Biosciences  shares were up 19% after the company said that its phase 2/3 registrational trial evaluating darovasertib in combination with crizotinib in patients with metastatic uveal melanoma met its primary endpoint.Leggett & Platt  stock was 7.2% higher after the company and Somnigroup International  said that Somnigroup has agreed to acquire Leggett & Platt in an all-stock transaction valued at about $2.50 billion.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4138","BATL","IDYA","LEG","BK7031","SGI","SGI.AU","SKYQ","BK7095","BK4213","LEG.AU","BK4585","BK4139","BK4095"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197511698","title":"Stock Track | IDEAYA Biosciences Soars 31.15% in Pre-market on Positive Phase 2/3 Trial Results for Eye Cancer Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=1197511698","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197511698?lang=en_us&edition=fundamental","pubTime":"2026-04-13 18:38","pubTimestamp":1776076722,"startTime":"0","endTime":"0","summary":"IDEAYA Biosciences (IDYA) stock surged 31.15% during pre-market trading on Monday following the announcement of positive clinical trial results for its experimental cancer treatment.The oncology...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["IDYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627434633","title":"Ideaya Biosciences Shares Jump on Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2627434633","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627434633?lang=en_us&edition=fundamental","pubTime":"2026-04-13 18:35","pubTimestamp":1776076500,"startTime":"0","endTime":"0","summary":"Shares of Ideaya Biosciences climbed after the company announced what it called positive top-line results from its melanoma-treatment trial.The stock jumped 36%, to $41.52, in premarket trading Monday. Through Friday's close, shares are up 82% over the past year.The oncology company said before the bell that its treatment, darovasertib, used in combination with crizotinib, resulted in a statistically significant improvement in median progression-free survival in patients with a certain type of melanoma in a Phase 2/3 registrational study with pharmaceutical group Servier.\"For patients with uveal melanoma, these results potentially offer a new treatment option that delivers a significant clinical advancement in both progression-free survival and overall response rate versus currently available therapies,\" Chief Executive Yujiro Hata said.Ideaya said that, based on these results, it will target the submission of a new drug application to the Food and Drug Administration in the second hal","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IDYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627431486","title":"BUZZ-IDEAYA Biosciences surges after eye cancer drug combo improves survival in trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2627431486","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627431486?lang=en_us&edition=fundamental","pubTime":"2026-04-13 18:19","pubTimestamp":1776075549,"startTime":"0","endTime":"0","summary":"BUZZ-IDEAYA Biosciences surges after eye cancer drug combo improves survival in trial** Shares of drug developer IDEAYA Biosciences IDYA.O rise 37.78% to $42 premarket** Co says its experimental combi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nL6N40W0KY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0456855351.SGD","BK4007","LU0122379950.USD","BK4581","BK4533","LU0225771236.USD","IE000M9KFDE8.USD","LU1883839398.USD","LU0306807586.USD","BK4592","IE00B19Z3B42.SGD","LU0234572021.USD","BK4585","LU1066053197.SGD","BK4534","LU1894683348.USD","LU1066051498.USD","LU0985481810.HKD","BK4568","LU0321505439.SGD","LU0868494617.USD","SG9999002224.SGD","BK4588","LU1057294990.SGD","IE0002270589.USD","SG9999001176.USD","IE00B19Z3581.USD","LU0321505868.SGD","IDYA","LU0289739699.SGD","SG9999002232.USD","IE00BBT3K403.USD","LU0058720904.USD","BK4599","LU1894683264.USD","LU0306806265.USD","SG9999013999.USD","SGXZ57979304.SGD","LU0225284248.USD","SG9999001176.SGD","IE00BLSP4452.SGD","LU1023059063.AUD","BK4139","SG9999003800.SGD","IE00BLSP4239.USD","LU0170899867.USD","SG9999011175.SGD","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627110431","title":"Ideaya Biosciences, Servier announce topline results from OptimUM-02 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2627110431","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627110431?lang=en_us&edition=fundamental","pubTime":"2026-04-13 18:19","pubTimestamp":1776075548,"startTime":"0","endTime":"0","summary":"Ideaya Biosciences (IDYA) and Servier announced topline results from their Phase 2/3 registrational trial, OptimUM-02, evaluating darovasertib in c...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ideaya-biosciences-servier-announce-topline-results-from-optimum-02-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ideaya-biosciences-servier-announce-topline-results-from-optimum-02-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","IDYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131239826","title":"U.S. Stocks to Watch: Goldman Sachs, SanDisk, Exxon Mobil, Nvidia, Ideaya, and More","url":"https://stock-news.laohu8.com/highlight/detail?id=1131239826","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131239826?lang=en_us&edition=fundamental","pubTime":"2026-04-13 18:10","pubTimestamp":1776075008,"startTime":"0","endTime":"0","summary":"Stock futures were falling Monday after peace talks between the U.S. and Iran faltered and President Donald Trump threatened to blockade the Strait of Hormuz.These stocks were making moves in...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNDK","GS","NVDA","IDYA","XOM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627431813","title":"Ideaya eye cancer drug meets main goal of mid-to-late-stage trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2627431813","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627431813?lang=en_us&edition=fundamental","pubTime":"2026-04-13 18:04","pubTimestamp":1776074695,"startTime":"0","endTime":"0","summary":"Ideaya eye cancer drug meets main goal of mid-to-late-stage trialApril 13  - Ideaya Biosciences IDYA.O said on Monday its drug for a type of eye cancer met the main goal of a mid-to-late-stage trial, after showing improvement in patients' survival without progression of the disease.  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nL4N40W0MM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627431864","title":"IDEAYA says darovasertib-crizotinib trial cuts progression risk 58% in metastatic uveal melanoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2627431864","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627431864?lang=en_us&edition=fundamental","pubTime":"2026-04-13 18:01","pubTimestamp":1776074490,"startTime":"0","endTime":"0","summary":"IDEAYA Biosciences reported positive topline results from OptimUM-02, a Phase 2/3 registrational trial of darovasertib with crizotinib in first-line HLA-A02:01-negative metastatic uveal melanoma.Trial met primary endpoint, showing patients on combination therapy stayed progression-free longer than investigator-choice immunotherapy.Study also showed higher tumor response rates for combination therapy, including complete responses, versus standard immunotherapy options.Overall survival data remain immature, though results showed an early favorable trend for combination therapy.Full trial data will be presented at a major medical conference in 2026; IDEAYA targets an FDA NDA submission in H2 2026 to support a US accelerated approval filing.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nNDL5ShScL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IDYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627439719","title":"IDEAYA Biosciences Shares Gain 18% Premarket Ahead of Data Release for Its Experimental Cancer Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2627439719","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627439719?lang=en_us&edition=fundamental","pubTime":"2026-04-13 18:00","pubTimestamp":1776074402,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nL4N40W0LU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IDYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627748439","title":"IDEAYA Biosciences Inc - Trial Met Primary Endpoint Showing Statistically Significant Improvement in Median Pfs by Bicr","url":"https://stock-news.laohu8.com/highlight/detail?id=2627748439","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627748439?lang=en_us&edition=fundamental","pubTime":"2026-04-13 18:00","pubTimestamp":1776074401,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nTUA2G2T5Q:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IDYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627439714","title":"IDEAYA Biosciences Inc - Nda Submission Planned for Second Half of 2026 to Support U.S. Accelerated Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2627439714","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627439714?lang=en_us&edition=fundamental","pubTime":"2026-04-13 18:00","pubTimestamp":1776074401,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nTUA2G2T5Q:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IDYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627439710","title":"IDEAYA Biosciences and Servier Announce Positive Topline Results From Phase 2/3 Registrational Trial (Optimum-02) of Darovasertib in Combination With Crizotinib in First-Line Hla-a*02:01-Negative Metastatic Uveal Melanoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2627439710","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627439710?lang=en_us&edition=fundamental","pubTime":"2026-04-13 18:00","pubTimestamp":1776074401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nTUA2G2T5Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IDYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627398484","title":"Why IDEAYA Biosciences Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket","url":"https://stock-news.laohu8.com/highlight/detail?id=2627398484","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627398484?lang=en_us&edition=fundamental","pubTime":"2026-04-13 17:27","pubTimestamp":1776072420,"startTime":"0","endTime":"0","summary":"IDEAYA Biosciences shares (NASDAQ: IDYA) jumped 18% in pre-market trading after announcing topline results from ongoing Phase 2/3 trial.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/04/13/Section-Of-A-Financial-Newspaper-Titled-.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/04/13/Section-Of-A-Financial-Newspaper-Titled-.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/26/04/51773369/why-ideaya-biosciences-shares-are-trading-higher-by-18-here-are-20-stocks-moving-premarket","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/26/04/51773369/why-ideaya-biosciences-shares-are-trading-higher-by-18-here-are-20-stocks-moving-premarket","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["IDYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627436996","title":"Analysts Offer Insights on Healthcare Companies: IDEAYA Biosciences (IDYA) and Certara (CERT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2627436996","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627436996?lang=en_us&edition=fundamental","pubTime":"2026-04-13 17:10","pubTimestamp":1776071429,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on IDEAYA Biosciences (IDYA) and Certara (CERT) with bu...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ideaya-biosciences-idya-and-certara-cert-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ideaya-biosciences-idya-and-certara-cert-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","HCSG","BK4585","BK4137","IDYA","LABU","XBI","BK4139","CERT","LU0128526141.USD","BK4588","LU0029874061.USD","BK4167","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626145582","title":"Ideaya Biosciences Shares Gain Ahead of Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2626145582","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626145582?lang=en_us&edition=fundamental","pubTime":"2026-04-11 05:52","pubTimestamp":1775857920,"startTime":"0","endTime":"0","summary":"Ideaya Biosciences shares rose after the company said it plans to release results of its melanoma treatment trial.The stock gained 18% to $36 in after-hours trading Friday. Through the close, shares were down 12%.The oncology company said it plans to disclose on Monday topline results from its ongoing trial with Servier.The trial is a Phase 2/3 registrational study evaluating darovasertib in combination with crizotinib in patients with a certain type of melanoma.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626148803","title":"BRIEF-Ideaya Biosciences To Announce Topline Results From Phase 2/3 Optimum-02 Trial In Metastatic Uveal Melanoma On Monday, April 13, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2626148803","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626148803?lang=en_us&edition=fundamental","pubTime":"2026-04-11 04:19","pubTimestamp":1775852354,"startTime":"0","endTime":"0","summary":"BRIEF-Ideaya Biosciences To Announce Topline Results From Phase 2/3 Optimum-02 Trial In Metastatic Uveal Melanoma On Monday, April 13, 2026April 10 (Reuters) - IDEAYA Biosciences Inc IDYA.O:IDEAYA BIO","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nTUA9ZCH3Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IDYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626111047","title":"IDEAYA to report topline OptimUM-02 darovasertib-crizotinib trial results April 13","url":"https://stock-news.laohu8.com/highlight/detail?id=2626111047","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626111047?lang=en_us&edition=fundamental","pubTime":"2026-04-11 04:06","pubTimestamp":1775851564,"startTime":"0","endTime":"0","summary":"IDEAYA Biosciences scheduled a pre-market press release and investor call for April 13, 2026 to disclose topline results from Phase 2/3 OptimUM-02.Results have not yet been presented; disclosure is planned for the April 13 event.OptimUM-02 evaluates darovasertib combined with crizotinib in first-line HLA-A2-negative metastatic uveal melanoma.Update is expected to clarify whether the regimen shows sufficient clinical benefit to support a registrational path in this patient group.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nNDL8G2D9C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IDYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626611049","title":"IDEAYA Biosciences to Announce Topline Results From Phase 2/3 Optimum-02 Trial in Metastatic Uveal Melanoma on Monday, April 13, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2626611049","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626611049?lang=en_us&edition=fundamental","pubTime":"2026-04-11 04:05","pubTimestamp":1775851500,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nTUA9ZCH3Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IDYA"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":199,"code":"91000000","status":"200"}]}}